ADM and COVID-19: Based on howRAMP2 affects adrenomedullin, this study demonstrates that the RAMP2 upregulation observed in the lung tissue of COVID-19 infected patients is most likely a compensatory response to lung injury caused by COVID-19, and is aimed at mitigating damage and inflammation.